Lotus Pharmaceutical Adjusts Investment Structure, Increases Capital in Singapore Subsidiary by US$18 Million
NQ Score
0/100
N1 Content Completeness
4
AI Summary (NQ-processed)
Lotus Pharmaceutical has decided to adjust its group investment structure by contributing the full ownership of its Japanese subsidiary, Lotus Japan Holdings Co., Ltd., as an in-kind investment of US$18 million to its Singapore subsidiary, Lotus International Pte. Ltd. This move aims to streamline operations and strengthen its international competitiveness in Asia.